42 research outputs found
Characterization of a Drosophila Alzheimer's Disease Model: Pharmacological Rescue of Cognitive Defects
Transgenic models of Alzheimer's disease (AD) have made significant contributions to our understanding of AD pathogenesis, and are useful tools in the development of potential therapeutics. The fruit fly, Drosophila melanogaster, provides a genetically tractable, powerful system to study the biochemical, genetic, environmental, and behavioral aspects of complex human diseases, including AD. In an effort to model AD, we over-expressed human APP and BACE genes in the Drosophila central nervous system. Biochemical, neuroanatomical, and behavioral analyses indicate that these flies exhibit aspects of clinical AD neuropathology and symptomology. These include the generation of Aβ40 and Aβ42, the presence of amyloid aggregates, dramatic neuroanatomical changes, defects in motor reflex behavior, and defects in memory. In addition, these flies exhibit external morphological abnormalities. Treatment with a γ-secretase inhibitor suppressed these phenotypes. Further, all of these phenotypes are present within the first few days of adult fly life. Taken together these data demonstrate that this transgenic AD model can serve as a powerful tool for the identification of AD therapeutic interventions
A comprehensive overview of radioguided surgery using gamma detection probe technology
The concept of radioguided surgery, which was first developed some 60 years ago, involves the use of a radiation detection probe system for the intraoperative detection of radionuclides. The use of gamma detection probe technology in radioguided surgery has tremendously expanded and has evolved into what is now considered an established discipline within the practice of surgery, revolutionizing the surgical management of many malignancies, including breast cancer, melanoma, and colorectal cancer, as well as the surgical management of parathyroid disease. The impact of radioguided surgery on the surgical management of cancer patients includes providing vital and real-time information to the surgeon regarding the location and extent of disease, as well as regarding the assessment of surgical resection margins. Additionally, it has allowed the surgeon to minimize the surgical invasiveness of many diagnostic and therapeutic procedures, while still maintaining maximum benefit to the cancer patient. In the current review, we have attempted to comprehensively evaluate the history, technical aspects, and clinical applications of radioguided surgery using gamma detection probe technology
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Thus, it is important to formulate on a regular basis updated guidelines for monitoring autophagy in different organisms. Despite numerous reviews, there continues to be confusion regarding acceptable methods to evaluate autophagy, especially in multicellular eukaryotes. Here, we present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes. These guidelines are not meant to be a dogmatic set of rules, because the appropriateness of any assay largely depends on the question being asked and the system being used. Moreover, no individual assay is perfect for every situation, calling for the use of multiple techniques to properly monitor autophagy in each experimental setting. Finally, several core components of the autophagy machinery have been implicated in distinct autophagic processes (canonical and noncanonical autophagy), implying that genetic approaches to block autophagy should rely on targeting two or more autophagy-related genes that ideally participate in distinct steps of the pathway. Along similar lines, because multiple proteins involved in autophagy also regulate other cellular pathways including apoptosis, not all of them can be used as a specific marker for bona fide autophagic responses. Here, we critically discuss current methods of assessing autophagy and the information they can, or cannot, provide. Our ultimate goal is to encourage intellectual and technical innovation in the field
Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration
Not Available
Not AvailableSuccessful purification of multiple viruses from mixed infections remains a
challenge. In this study, we investigated peste des petits ruminants virus (PPRV)
and foot-and-mouth disease virus (FMDV) mixed infection in goats. Rather than in
a single cell type, cytopathic effect (CPE) of the virus was observed in
cocultured Vero/BHK-21 cells at 6th blind passage (BP). PPRV, but not FMDV could
be purified from the virus mixture by plaque assay. Viral RNA (mixture)
transfection in BHK-21 cells produced FMDV but not PPRV virions, a strategy which
we have successfully employed for the first time to eliminate the
negative-stranded RNA virus from the virus mixture. FMDV phenotypes, such as
replication competent but noncytolytic, cytolytic but defective in plaque
formation and, cytolytic but defective in both plaque formation and standard FMDV
genome were observed respectively, at passage level BP8, BP15 and BP19 and hence
complicated virus isolation in the cell culture system. Mixed infection was not
found to induce any significant antigenic and genetic diversity in both PPRV and
FMDV. Further, we for the first time demonstrated the viral interference between
PPRV and FMDV. Prior transfection of PPRV RNA, but not Newcastle disease virus
(NDV) and rotavirus RNA resulted in reduced FMDV replication in BHK-21 cells
suggesting that the PPRV RNA-induced interference was specifically directed
against FMDV. On long-term coinfection of some acute pathogenic viruses (all
possible combinations of PPRV, FMDV, NDV and buffalopox virus) in Vero cells, in
most cases, one of the coinfecting viruses was excluded at passage level 5
suggesting that the long-term coinfection may modify viral persistence. To the
best of our knowledge, this is the first documented evidence describing a natural
mixed infection of FMDV and PPRV. The study not only provides simple and reliable
methodologies for isolation and purification of two epidemiologically and
economically important groups of viruses, but could also help in establishing
better guidelines for trading animals that could transmit further infections and
epidemics in disease free nations.Not Availabl
The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer
Purpose: Introduced in 1987, platinum-based chemotherapy remains standard of care for small cell
lung cancer, a most aggressive, recalcitrant tumor. Prominent barriers to progress are paucity of
tumor tissue to identify drug targets and patient relevant models to interrogate novel therapies.
Following our development of circulating tumour cell patient-derived explants (CDX) as models that
faithfully mirror patient disease, here we exploit CDX to examine new therapeutic options for small
cell lung cancer.
Experimental Design: We investigated the efficacy of the PARP inhibitor olaparib alone or in
combination with the Wee1 kinase inhibitor AZD1775 in ten phenotypically distinct SCLC CDX in vivo
and/or ex vivo. These CDX represent chemosensitive and chemorefractory disease including the first
reported paired CDX generated longitudinally before treatment and upon disease progression.
Results: There was a heterogeneous depth and duration of response to olaparib/AZD1775 which
diminished when tested at disease progression. However, efficacy of this combination consistently
exceeded that of cisplatin/etoposide with cures in one CDX model. Genomic and protein analyses
revealed defects in homologous recombination repair and oncogenes that induce replication stress
(such as MYC family members), predisposed CDX to combined olaparib/AZD1775 sensitivity though
universal predictors of response were not noted.
Conclusions: These preclinical data provide a strong rationale to trial this combination in the clinic
informed by prevalent, readily accessed circulating tumor cell based biomarkers. New therapies will
be evaluated in SCLC patients after first line chemotherapy and our data suggest that the
combination of olaparib/AZD1775 should be used as early as possible and prior to disease relapse